NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $49.64 -0.26 (-0.52%) (As of 07/8/2024 ET) Add Compare Share Share Today's Range$49.58▼$50.4250-Day Range$49.64▼$66.4352-Week Range$49.53▼$96.05Volume1.19 million shsAverage Volume1.82 million shsMarket Capitalization$8.57 billionP/E RatioN/ADividend YieldN/APrice Target$63.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Get Solventum alerts: Email Address Ad Chaikin Analytics50-year Wall Street Legend: “Prepare for a cash avalanche”The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the start of the year.So why are top hedge funds currently dumping their stocks? About SolventumSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.Read More SOLV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SOLV Stock News HeadlinesJune 18, 2024 | marketbeat.com3M Stock: Invest Now for Unmatched Quality and Growth Potential (SOLV)3M is a high-quality dividend-paying stock with diminishing headwinds and catalysts forming that could increase the market by 50%.July 7 at 5:30 PM | seekingalpha.comSolventum: Stumbling Out Of The GateJuly 9, 2024 | Wealthpin Pro (Ad)The Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.July 2, 2024 | prnewswire.comU.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals RankingsJune 24, 2024 | prnewswire.comSolventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenueJune 18, 2024 | investorplace.comContrarian Plays: 3 Stocks to Buy When Analysts Say ‘Sell'June 12, 2024 | seekingalpha.comSolventum: 3 Reasons Why This Healthcare Spinoff Is A SellJune 7, 2024 | prnewswire.comSolventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"July 9, 2024 | Wealthpin Pro (Ad)The Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.June 6, 2024 | globenewswire.comTRC Amends Its Tender Offer for Solventum CorporationMay 17, 2024 | seekingalpha.comSolventum: A Reasonable Start, Still Some Questions To Be AskedMay 16, 2024 | investorplace.comDivide and Conquer: 3 Stock Spinoffs Set to Trounce the MarketMay 11, 2024 | finance.yahoo.comDecoding Solventum Corp (SOLV): A Strategic SWOT InsightMay 10, 2024 | msn.comB of A Securities Initiates Coverage of Solventum (SOLV) with Neutral RecommendationMay 9, 2024 | finance.yahoo.comUnit Corporation Reports First Quarter ResultsMay 9, 2024 | msn.com3M health care spinoff Solventum prioritizing paying down $8.3B long-term debtMay 9, 2024 | finance.yahoo.comSolventum's first-quarter profit falls 19% on lower surgical product salesMay 9, 2024 | barrons.comSolventum Reports Earnings. There Will Be No Dividend.See More Headlines Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/08/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:SOLV Previous Symbol: CUSIPN/A CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$63.25 High Stock Price Target$70.00 Low Stock Price Target$54.00 Potential Upside/Downside+27.4%Consensus RatingReduce Rating Score (0-4)1.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio7.97 P/E Growth1.14Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio2.16 Current Ratio1.81 Quick Ratio1.33 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares172,710,000Free FloatN/AMarket Cap$8.57 billion OptionableOptionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Bryan C. Hanson (Age 57)CEO & Director Mary T. WilcoxChief Accounting OfficerMs. Amy LanducciChief Information & Digital OfficerMr. Paul S. HarringtonChief Supply Chain OfficerMichael J. OttesenVice PresidentKey CompetitorsResMedNYSE:RMDWest Pharmaceutical ServicesNYSE:WSTBaxter InternationalNYSE:BAXInsuletNASDAQ:PODDTeleflexNYSE:TFXView All CompetitorsInstitutional OwnershipST Germain D J Co. Inc.Bought 1,768 shares on 7/8/2024Ownership: 0.001%City State BankBought 1,005 shares on 7/8/2024Ownership: 0.001%Bank & Trust CoBought 945 shares on 7/8/2024Ownership: 0.001%Beach Investment Counsel Inc. PABought 510 shares on 7/8/2024Ownership: 0.000%Thurston Springer Miller Herd & Titak Inc.Bought 558 shares on 7/5/2024Ownership: 0.000%View All Institutional Transactions SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $66.90 at the beginning of 2024. Since then, SOLV shares have decreased by 25.8% and is now trading at $49.64. View the best growth stocks for 2024 here. How were Solventum's earnings last quarter? Solventum Co. (NYSE:SOLV) posted its quarterly earnings data on Thursday, May, 9th. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.67 by $0.41. The business had revenue of $2.02 billion for the quarter, compared to analyst estimates of $1.99 billion. Who are Solventum's major shareholders? Top institutional shareholders of Solventum include DNB Asset Management AS (0.01%), ST Germain D J Co. Inc., GAMMA Investing LLC and City State Bank. How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:SOLV) was last updated on 7/9/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house...Wealthpin Pro | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | SponsoredTop Hedge Funds Reveal A.I. Moonshot CoinsThe manager of top crypto hedge fund Pantera recently said every crypto company will soon be an artificial int...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
